Trademark Encyclopedia

Information about trademarks

Search for trademarks:

• 0
• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• A
• B
• C
• D
• E
• F
• G
• H
• I
• J
• K
• L
• M
• N
• O
• P
• Q
• R
• S
• T
• U
• V
• W
• X
• Y
• Z

Table of contents:

• Document 85132643 overview
• GOODS AND/OR SERVICES CLASS
• PROSECUTION HISTORY
• Document 85978093 overview

---

---

The "LIPOQIN" trademark, serial number 85132643 , was filed on 17th of September 2010 with a mark drawing code of 4000 and its transaction date is 85132643. The attorney assigned is Harold Milstein, attorney docket number 037W. Since 28th of March 2014, the document can be found in the L60 law office in the publication and issue section. The employee responsible is GUTTADAURO, JULIE MARI and the date it was published for opposition on 03/01/2011. The date when we last checked the status of this trademark was 05/27/2013.

Prior registrations: 85978093 (Continuity Child)

The corresponded responsible for this trademark is Harold Milstein, located at Sheppard Mullin Richter & Hampton LLP, 379 Lytton Avenue, Palo Alto CA 94301-1479.

The state or country where the trademark was organized is CA by Aradigm Corporation. The legal entity type behing it is a Corporation, located at 3929 Point Eden Way, Hayward, CA zip 94545.

GOODS AND/OR SERVICES
International Class - 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
U.S. Class	044 - Dental, Medical, and Surgical Appliances
Class Status	6 - Active
Status Date	09/23/2010
Primary Code	010
Goods codes
GS0101	Pharmaceutical drug delivery device for the administration of pharmaceutical preparations via inhalation

MADRID PROTOCOL INFORMATION
USPTO Reference Number	A0023564
Original Filing Date with USPTO	03/08/2011
International Registration Number	1071003
International Registration Date	03/08/2011
International Registration Status	APPLICATION FOR IR REGISTERED BY IB
Date of International Registration Status	04/14/2011
International Registration Renewal Date	03/08/2021

MADRID HISTORY
Date	Description	Code
03/08/2011	AUTOMATICALLY CERTIFIED	ACERT - AUTOMATICALLY CERTIFIED
03/08/2011	NEW APPLICATION FOR IR RECEIVED	NEWAP - NEW APPLICATION FOR IR RECEIVED
03/08/2011	IR CERTIFIED AND SENT TO IB	APPST - IR CERTIFIED AND SENT TO IB
04/15/2011	APPLICATION FOR IR REGISTERED BY IB	CREAT - APPLICATION FOR IR REGISTERED BY IB
12/19/2011	SUBSEQUENT DESIGNATION RECEIVED	SDRCV - SUBSEQUENT DESIGNATION RECEIVED
12/19/2011	SUBSEQUENT DESIGNATION SENT TO IB	SDSNT - SUBSEQUENT DESIGNATION SENT TO IB
12/08/2012	DIVISIONAL OF BASE APP NOTICE CREATED, TO BE SENT TO IB	DBCRP - DIVISIONAL OF BASE APP NOTICE CREATED, TO BE SENT TO IB
12/10/2012	DIVISIONAL OF BASE APP NOTICE SENT TO IB	DBCSP - DIVISIONAL OF BASE APP NOTICE SENT TO IB
05/14/2013	PARTIAL CEASING OF EFFECT TO BE PROCESSED	CBPCP - PARTIAL CEASING OF EFFECT NOTICE CREATED, TO BE SENT TO IB
08/05/2013	CEASING OF EFFECT PROCESSED	CBMPP
08/05/2013	PARTIAL CEASING OF EFFECT NOTICE SENT TO IB	CBPSP - PARTIAL CEASING OF EFFECT NOTICE SENT TO IB
11/29/2013	PARTIAL CEASING OF EFFECT TO BE PROCESSED	CBPCP - PARTIAL CEASING OF EFFECT NOTICE CREATED, TO BE SENT TO IB
12/09/2013	PARTIAL CEASING OF EFFECT PROCESSED BY IB	PCBNP - PARTIAL CEASING OF EFFECT PROCESSED BY IB
03/28/2014	CEASING OF EFFECT PROCESSED	CBMPP
03/28/2014	PARTIAL CEASING OF EFFECT NOTICE SENT TO IB	CBPSP - PARTIAL CEASING OF EFFECT NOTICE SENT TO IB

PROSECUTION HISTORY
Date	Description	Type	Code
05/28/2013	ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED	O - Outgoing Correspondence	MAB6 - ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
05/27/2013	ABANDONMENT - NO USE STATEMENT FILED	S	ABN6 - ABANDONMENT - NO USE STATEMENT FILED
12/08/2012	CORRECTED NOA E-MAILED	E	NOAC
12/07/2012	DIVISIONAL PROCESSING COMPLETE	D - Assigned to Examiner	DPCC - DIVISIONAL PROCESSING COMPLETE
10/31/2012	DIVISIONAL REQUEST RECEIVED	I - Incoming Correspondence	DRRR - DIVISIONAL REQUEST RECEIVED
10/31/2012	TEAS REQUEST TO DIVIDE RECEIVED	I - Incoming Correspondence	ERTD
10/23/2012	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	E	EXRA
10/22/2012	EXTENSION 3 GRANTED	S	EX3G - EXTENSION 3 GRANTED
10/18/2012	EXTENSION 3 FILED	S	EXT3 - EXTENSION 3 FILED
10/18/2012	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
04/20/2012	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	E	EXRA
04/19/2012	EXTENSION 2 GRANTED	S	EX2G - EXTENSION 2 GRANTED
03/22/2012	EXTENSION 2 FILED	S	EXT2 - EXTENSION 2 FILED
04/18/2012	CASE ASSIGNED TO INTENT TO USE PARALEGAL	A - Allowance for Publication	AITU
03/22/2012	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
11/17/2011	TEAS CHANGE OF CORRESPONDENCE RECEIVED	I - Incoming Correspondence	TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/21/2011	NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED	E	EXRA
10/19/2011	EXTENSION 1 GRANTED	S	EX1G - EXTENSION 1 GRANTED
10/19/2011	EXTENSION 1 FILED	S	EXT1 - EXTENSION 1 FILED
10/19/2011	TEAS EXTENSION RECEIVED	I - Incoming Correspondence	EEXT - TEAS EXTENSION RECEIVED
04/26/2011	NOA E-MAILED - SOU REQUIRED FROM APPLICANT	E	NOAM
03/01/2011	OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED	E	NPUB - NOTICE OF PUBLICATION
03/01/2011	PUBLISHED FOR OPPOSITION	A - Allowance for Publication	PUBO - PUBLISHED FOR OPPOSITION
01/27/2011	LAW OFFICE PUBLICATION REVIEW COMPLETED	O - Outgoing Correspondence	PREV - LAW OFFICE PUBLICATION REVIEW COMPLETED
01/27/2011	ASSIGNED TO LIE	A - Allowance for Publication	ALIE - ASSIGNED TO LIE
12/26/2010	APPROVED FOR PUB - PRINCIPAL REGISTER	P	CNSA - APPROVED FOR PUB - PRINCIPAL REGISTER
12/26/2010	ASSIGNED TO EXAMINER	D - Assigned to Examiner	DOCK - ASSIGNED TO EXAMINER
12/06/2010	TEAS CHANGE OF CORRESPONDENCE RECEIVED	I - Incoming Correspondence	TCCA - TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/23/2010	NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	I - Incoming Correspondence	NWOS
09/21/2010	NEW APPLICATION ENTERED IN TRAM	I - Incoming Correspondence	NWAP - NEW APPLICATION ENTERED IN TRAM

Some parts © 2024 Advameg, Inc.